secwatch.observer — SEC 8-K summary
======================================

Issuer:     Imunon, Inc. (IMNN)
CIK:        0000749647
Form:       8-K
Filed at:   2025-08-28T23:59:59+00:00
Accession:  0001493152-25-012417
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Imunon regains Nasdaq minimum bid price compliance; trading continues uninterrupted
--------------------------------------------------------------------------------

- Received Nasdaq Hearings Panel confirmation of regained compliance with $1.00 minimum bid price rule (Rule 5550(a)(2)).
- Common stock (IMNN) to continue trading on Nasdaq Capital Market without interruption.
- CEO notes recent 15% stock dividend and momentum from Phase 2 OVATION 2 trial for IMNN-001 in ovarian cancer.
- Phase 3 OVATION 3 trial for IMNN-001 successfully initiated in North America.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/749647/000149315225012417/0001493152-25-012417-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/749647/000149315225012417/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-012417

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer